摘要
目的研究冻干重组人脑利钠肽治疗充血性心衰的疗效和安全性。方法选择我院收治的102例充血性心衰患者为研究对象,随机分为两组,其中给予对照组常规治疗,观察组则运用冻干重组人脑利钠肽治疗,对比分析两组的疗效。结果观察组的治疗总有效率高于对照组,P<0.05,差异具有统计学意义。结论临床上运用冻干重组人脑利钠肽治疗充血性心衰,可以获得较好的效果。
Objective To explore the treatment of congestive heart failure to use the new fuel.Methods Selected 102 cases of patients with congestive heart failure in our hospital as the research object, and randomly divided into two groups, which give the control group routine treatment, the observation group to used new fuel treatment, compared two groups of curative effect.ResultsThe total effective rate of observation group was higher than the control group,P〈0.05, had difference statistically significance.Conclusion The clinical use of new active element in the treatment of congestive heart failure, can obtain good effect.
出处
《中国继续医学教育》
2015年第26期130-131,共2页
China Continuing Medical Education
关键词
充血性心衰
新活素
疗效
Congestive heart failure
New living element
Curative effect
